Modern Healthcare June 15, 2020
Jessica Kim Cohen

Apple has expanded the scope of its smartwatch’s electrocardiogram app, which can now be used as a replacement for an in-clinic ECG during the COVID-19 public health emergency.

The expansion takes advantage of guidance the Food and Drug Administration released to expand the availability of non-invasive remote patient-monitoring technologies during the COVID-19 pandemic, as part of an effort to allow physicians to treat patients remotely without needing them to visit a healthcare facility.

Under that guidance, physicians can use the Apple Watch’s ECG app to support diagnosis of certain arrhythmias and manage related conditions while treating patients via telemedicine, according to Apple.

To support that expanded capability, patients can export a PDF of the ECG app’s waveform recording and patient-reported...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, FDA, Govt Agencies, Healthcare System, Patient / Consumer, Physician, Provider, Public Health / COVID, Technology, Wearables
Q&A: Bring your own device: How patients own tech is being used in clinical trials
AR and VR Have Potential to Reshape Wearable Tech Landscape
Ultrahuman Opens U.S. Manufacturing Facility for Wearable Rings
The Iyo One earbuds are the latest in wearable AI
Emerging Trends in Pain Management Technologies

Share This Article